Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 52886X107

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Integrated Core Strategies (US) LLC

    Shares: 2,641,811.00 · Class: 4.9%

  • Millennium Management LLC

    Shares: 2,836,292.00 · Class: 5.3%

  • Millennium Group Management LLC

    Shares: 2,836,292.00 · Class: 5.3%

  • Israel A. Englander

    Shares: 2,836,292.00 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-075208
Form type
SCHEDULE 13G/A
Filer
INTEGRATED CORE STRATEGIES (US) LLC
CIK
CIK 1319244
Filed
Aug 07, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub